About the Activity

Learning Objectives

After completion of this educational activity, the participant should be able to

• develop a protocol for routine screening for and differential diagnosis of anemia four weeks before the scheduled date of elective surgery;


• identify patients for whom erythropoiesis-stimulating agents (ESAs) may be indicated;


• safely decrease the rate of administering allogeneic transfusions to surgical patients;


• analyze the cost/benefit ratio for treating anemia preoperatively with ESAs vs perioperatively with allogeneic transfusion.

Faculty

CHAIR

Richard K. Spence, MD, MHA, FACS
Medical Officer
Infonalé, A Haemonetics Company
Braintree, Massachusetts

FACULTY

Lawrence Tim Goodnough, MD
Professor of Pathology and Medicine
Stanford University School of Medicine
Stanford, California

Patricia Parce, RN, CCRC
Director, Clinical Program Development
Infonalé, A Haemonetics Company
Braintree, Massachusetts

Aryeh Shander, MD, FCCM, FCCP
Chief, Department of Anesthesiology
Critical Care and Hyperbaric Medicine
Englewood Hospital and Medical Center
Englewood, New Jersey
Clinical Professor of Anesthesiology, Medicine, and Surgery
Mount Sinai School of Medicine
New York, New York

Statements and Disclaimers

AdvancMed is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation Statement
AdvancMed designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AdvancMed provides this activity for 2.5 nursing contact hours.

Provider approved by the California Board of Registered Nursing, Provider Number 13429 for 2.5 contact hours.

Acknowledgment of Commercial Support
AdvancMed gratefully acknowledges Ortho Biotech Clinical Affairs, LLC for the educational grant in support of this activity.

Statement of Origin
The presentations and discussions presented in this Web activity are proceedings from a live satellite symposium, presented in conjunction with the 6th Annual Meeting of the Society for the Advancement of Blood Management, held on September 8, 2007, in Hollywood, California.

Off-label Statement/Unapproved Uses
In accordance with the Standards for Commercial Support and the Policy Compendium of the Accreditation Council for Continuing Medical Education, the audience is advised that one or more presentations in this continuing medical education activity may contain reference(s) to uses of drugs or devices that are off-label, investigational, or unapproved in the United States. This information is intended solely as continuing medical education and not to endorse off-label use. For US Food and Drug Administration (FDA)-approved prescribing information, please consult the product package insert.

Disclosure Statement
In accordance with the appropriate accrediting bodies, all planners, teachers, and authors with control over activity content are required to disclose to the provider any relevant financial relationships (those held by the planner or significant other, currently or within the last 12 months) with commercial interests. Accredited providers are then required to provide this information to participants before the start of an activity.